Locations
United States · Massachusetts, USA · Switzerland · Cambridge, MA, USA · Basel, Switzerland · North America · Cambridge, MA, USA · United Kingdom · London, UK
industry
Biotechnology · DeepTech · Health
Size
201-1000 employees
Stage
Other
founded in
2013
CRISPR Therapeutics is focused on the development of transformative medicines using its proprietary CRISPR/Cas9 gene-editing platform. CRISPR/Cas9 is a revolutionary technology that allows for precise, directed changes to genomic DNA. They have licensed the foundational CRISPR/Cas9 patent estate for human therapeutic use from their scientific founder, Dr. Emmanuelle Charpentier, who co-invented the application of CRISPR/Cas9 for gene editing. CRISPR Therapeutics’ vision is to cure serious human diseases at the molecular level using CRISPR-Cas9. The company is headquartered in Basel, Switzerland and has operations in London, UK.
Something looks off?On-site & Remote